Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2026 / Articles / June / This Week’s Biopharma News: New Approvals, Appeals, and AI
Biopharma Biopharma Industry News Research News Sponsored

This Week’s Biopharma News: New Approvals, Appeals, and AI

Datroway and Hepcludex secure notable FDA approvals, while Outlook wins its bevacizumab appeal, BioMarin reports phase 3 VOXZOGO data, and BMS partners with Anthropic

06/02/2026 6 min read News
  • Full Article
  • Summary
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Top Institutions

Share

Top Institutions in Pharmacology

Ranking combines internal corpus citation frequency with web search results due to limited internal data for this topic.

  • #1

    University of California, San Francisco

    San Francisco, California

    UCSF is recognized for its extensive NIH funding and a large portfolio of clinical trials, making it a leader in pharmacology research.

    Key Differentiators

    • Pharmacology
    • Drug Development
    • Clinical Trials
  • #2

    Stanford University/Stanford Health Care

    Stanford, California

    Stanford Health Care is noted for its innovative research programs in drug development and artificial intelligence in medicine.

    Key Differentiators

    • Pharmacology
    • Translational Medicine
  • #3

    Tufts Center for the Study of Drug Development

    Medford, Massachusetts

    Tufts provides valuable insights into integrated approaches in drug development, contributing to the biopharma sector.

    Key Differentiators

    • Pharmacology
    • Drug Development
  • #4

    The Hastings Center

    Garrison, New York

    The Hastings Center is a nonpartisan research institution that addresses ethical issues in drug development and approval processes.

    Key Differentiators

    • Bioethics
    • Pharmacology
  • #5

    Wills Eye Hospital

    Philadelphia, Pennsylvania

    Wills Eye Hospital is involved in research on the financial benefits of anti-VEGF therapy, contributing to pharmacological advancements.

    Key Differentiators

    • Ophthalmology
    • Pharmacology

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Recommended

Related Content

What Trump’s Latest Moves Mean for the Industry
Interviews Bioprocessing Business & Trends
What Trump’s Latest Moves Mean for the Industry

May 27, 2025

6 min read

Audrey Greenberg’s latest insight on US-based manufacturing, Trump’s “Administration for A Healthy America”, and an ever-shifting regulatory environment.

Pass Me a Bottle Opener
Bioprocessing Biopharma
Pass Me a Bottle Opener

December 1, 2014

0 min read

Upstream processes in biopharma manufacturing are growing ever more efficient; conversely, downstream processing is increasingly a bottleneck. Can a new generation of chromatography techniques and technologies get things moving again?

The Next Decade of Cell and Gene Therapies
Cell & Gene Bioprocessing Biopharma
The Next Decade of Cell and Gene Therapies

April 2, 2025

5 min read

Off-the-shelf allogeneic CAR-Ts, increased manufacturing productivity led by digital systems, and more; we ask experts about the future of advanced medicine.

Biotech Versus the Superbugs
Bioprocessing Biopharma Drug Discovery
Biotech Versus the Superbugs

April 7, 2025

6 min read

Meet one company and its new drug candidate in the fight against gram-negative bacterial infections.

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions: